Congenital melanotic naevi
News
15.06.2017
Syneron Candela’s PicoWay picosecond laser now with three wavelengths and resolve fractional
PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for a new ultra-short 785 nm wavelength, making it the third FDA cleared wavelength for PicoWay. The new ultra-short […]
10.02.2025
Global Consensus for the Management of Acute Complications from Hyaluronic Acid Injections in Aesthetic Medicine
The increasing popularity of hyaluronic acid (HA) injections in aesthetic medicine is associated with rising numbers of cases of rare but serious vascular complications such as ischemia, necrosis, scarring, and […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]